[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545146":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":26,"locations":36,"responsibleParty":56,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":12,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":12,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":39,"whyStopped":12,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Universidad de Antioquia","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control Group (standard management + education on responsible self-medication)","NO_INTERVENTION","Patients will receive standard management + education on responsible self-medication. This group will have three activities: 1. Voluntary selection of OTC medication, 2. Health education on what responsible self-medication entails, 3. Monitoring for moderate and serious ADRs related to the use of selected nonprescription drugs or worsening symptoms of the MA, with referral to a GP if necessary.\n\nFor each MA, the Pharmacist will request the patient's signature on Annex 1, proceed with Activity 1, fill in the instrument included in Annex 4, and continue with Activity 2.\n\nOn days 3, 5, 7, and 10 after the consultation, patients will be contacted via a chatbot or a phone call to answer Annex 5. On days 5 to 6, and 10 to 12, a pharmacist of the research team will review patient responses to evaluate the need for medical referral (Activity 3), if the presence of a moderate or serious ADR or worsening of the symptom is identified (T5-T6, T10-T12).",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention Group (management using CBPs)","EXPERIMENTAL","Patients will receive management using CBPs. This group will have four activities: 1. Identification and classification of the MA, 2.Referral to a GP if the patient's condition is not classified as an MA, 3. Patient guidance on appropriate pharmacological measures in case an OTC medication is required 4. Monitoring for moderate or serious ADRs related to the use of selected nonprescription drugs or worsening symptoms of the MA, with referral to a GP if necessary.\n\nFor each MA, the Pharmacist will request the patient's Informed Consent, apply what is described in Activities 1, 2, and 3, and fill in the instrument included in Annex 4.\n\nDays 3, 5, 6, 7, 10, and 12 will be followed as described for control group.",[18],"Other: Patient guided and followed by the pharmacist",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Patient guided and followed by the pharmacist","The Study Coordinating Group will train the pharmacy Staff regarding these protocols.\n\nThis training will cover both pharmacological and non-pharmacological aspects of MA management. The pharmacological component will emphasize the appropriate selection and safe use of nonprescription drugs, with a focus on identifying potential drug interactions, contraindications, and moderate and serious ADRs. Pharmacy staff will also be equipped with tools to apply proper criteria for referral to a GP when necessary.\n\nThe staff will be divided into three groups, and every group will have a minimum of two sessions, each one of 4 hours. Additionally, there will be a practical component where simulations of real situations will be conducted.\n\nThroughout the 12-month follow-up and intervention period, one of the researchers will be available to receive phone calls to address doubts and concerns about the Consensus-based Protocols.",[14],[25],"Use of consensus-based protocols",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":12,"email":31},"Andrea Salazar","CONTACT","+573017971909","asalazarospina@gmail.com",{"name":33,"role":29,"phone":34,"phoneExt":12,"email":35},"Milena Ortiz","+573175007349","milena.ortizr@udea.edu.co",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Farmacias Pasteur S.A.","RECRUITING","Medellín","Antioquia","050001","Colombia","CO",{"type":46,"coordinates":47},"Point",[48,49],-75.57151,6.245,{"lat":49,"lon":48},[52],{"name":53,"role":29,"phone":54,"phoneExt":12,"email":55},"Olga Henao","+573103895657","ohenao@pasteur.com.co",{"type":57,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Pedro Amariles","Professor",[61],{"name":62,"class":63},"Farmacias Pasteur","UNKNOWN","100545146","evaluation-of-the-effect-of-consensus-based-protocols-for-the-treatment-of-minor-ailments-100545146",false,"NCT06378099","Evaluation of the Effect of Consensus-based Protocols for the Treatment of Minor Ailments","Evaluation of the Effect of Consensus-based Protocols for the Treatment of Minor Ailments in Drugstores and Pharmacies in Medellin and the Metropolitan Area, Colombia: A Randomized Clinical Trial.","Inclusion Criteria:\n\nDrugstores and drugstores\u002Fpharmacies:\n\n* Establishments located in Medellin and Metropolitan area\n* Establishments that have a Pharmacy Technician serving as the technical director.\n* Establishments with electronic point-of-sale system for data collection.\n* Commitment to participate for the full 10-month study period.\n\nParticipants (patients):\n\n* Explicit consent to participate in the study.\n* Are the direct consumers requesting the nonprescription drug (i.e., not requesting them on behalf of someone else).\n* Present one of the five predefined potential MA that will be included in the study: influenza-like syndrome and catarrh, headache, common cold, sore throat, and menstrual pain or cramps.\n* Have access to mobile phone for follow-upThe person requesting the OTC medication must be the end consumer of it.\n\nExclusion Criteria:\n\n* Subjects who refuse to sign the informed consent\n* Subjects with an evident incapacity to complete the data questionnaire\n* Pregnant or breastfeeding women\n* Patients whose MA result from an ADR\n* Patients with symptoms lasting more than seven days","ALL","18 Years","65 Years",{"count":75,"type":76},900,"ESTIMATED","INTERVENTIONAL",[79],"NA","Minor ailments are common, self-limited conditions unrelated to the patient's underlying health problems or adverse effects of their current medications. Minor ailment services are pharmacist-led interventions that provide patients with the most appropriate recommendation when unsure about the medication for a specific minor ailment. It involves advice on nonprescription drugs, non-pharmacological measures, or referral to another health care practitioner. In Colombia, evaluating and implementing this service could optimize nonprescription drugs use and improve minor ailment management in primary health care settings.",[82],"Community Pharmacy Services",[84,85,86,87,88,89,90,91,92],"Minor ailments","Minor Ailment Services","Pharmacies","Nonprescription drugs","Pharmacy Technicians","Health education","Self care","Ambulatory care","Community Health Services","2025-08-27",{"date":95,"type":96},"2025-08-29","ACTUAL",{"date":98,"type":96},"2024-12-04",{"date":100,"type":76},"2025-10",{"name":5,"class":6},1]